<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24173195</article-id>
      <article-id pub-id-type="pmc">3798366</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132258</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>What Is Your Diagnosis?</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Case for diagnosis<sup><xref ref-type="fn" rid="fn03">*</xref></sup></article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Caso para diagn&#xF3;stico</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pedrosa</surname>
            <given-names>Ana Filipa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ferreira</surname>
            <given-names>Olga</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barros</surname>
            <given-names>Ana Margarida</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nogueira</surname>
            <given-names>Ana</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bettencourt</surname>
            <given-names>Herberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Azevedo</surname>
            <given-names>Filomena</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD - Resident in the Department of Dermatology and Venereology, Centro
Hospitalar S&#xE3;o Jo&#xE3;o, EPE - Porto, Portugal.</aff>
      <aff id="aff02"><label>2</label> MD - Specialist in the Department of Dermatology and Venereology,
Centro Hospitalar S&#xE3;o Jo&#xE3;o, EPE - Porto, Portugal.</aff>
      <aff id="aff03"><label>3</label> MD - Specialist in the Department of Pathology, Centro Hospitalar S&#xE3;o
Jo&#xE3;o, EPE - Porto, Portugal </aff>
      <aff id="aff04"><label>4</label> MD - Specialist and Head of the Department of Dermatology and
Venereology, Centro Hospitalar S&#xE3;o Jo&#xE3;o, EPE - Porto, Portugal.</aff>
      <author-notes>
        <corresp id="c01"> MAILING ADDRESS: Ana Filipa Bastos Pedrosa, Alameda Professor Hernani
Monteiro, 4200-319 - Porto - Portugal, E-mail:
<email>anabastospedrosa@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>5</issue>
      <fpage>824</fpage>
      <lpage>825</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>12</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Ketron-Goodman disease was formerly considered a disseminated type of pagetoid
reticulosis. However, according to the new classification consensus, it should be
regarded as aggressive epidermotropic CD8 T-cutaneous lymphoma, cutaneous gamma/delta
T-lymphoma, or tumor-stage mycosis fungoides, depending on the clinical-histological
picture. This case highlights a rare and challenging presentation of Ketron-Goodman
disease with an indolent presentation and evolution and good response to a low-grade
treatment regimen, not fitting well into the new classification criteria.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A doen&#xE7;a de Ketron-Goodman foi inicialmente considerada uma forma disseminada de
reticulose paget&#xF3;ide. Mas, de acordo com o atual sistema de classifica&#xE7;&#xE3;o e
dependendo do quadro cl&#xED;nico-patol&#xF3;gico deve ser antes vista como um linfoma T CD8
agressivo epidermotr&#xF3;pico, linfoma T gama/delta ou micose fung&#xF3;ide, estadio tumoral.
Pretendemos real&#xE7;ar esta doen&#xE7;a rara que pode suscitar d&#xFA;vidas no diagn&#xF3;stico. Neste
caso, a apresenta&#xE7;&#xE3;o e evolu&#xE7;&#xE3;o foram indolentes com boa resposta a um tratamento
pouco agressivo, n&#xE3;o se enquadrando bem nas novas propostas de classifica&#xE7;&#xE3;o da
doen&#xE7;a.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Lymphoma, T-Cell, cutaneous</kwd>
        <kwd>Mycosis fungoides</kwd>
        <kwd>Pagetoid reticulosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>CASE REPORT</title>
      <p>A 53-year-old Caucasian male was referred to our Department due to an asymptomatic
erythematous plaque on the left buttock evolving for 5 months and with progressive
increase. On physical examination, an erythematous-brownish plaque was observed with a
raised erythematous-red border and areas of erosion (<xref ref-type="fig" rid="f01">Figure 1</xref>). There were no other signs or symptoms. A biopsy showed
hyperkeratosis, acanthosis and spongiosis, as well as epidermotropism of isolated and
grouped large-sized atypical lymphocytes with pale halos, also present in the upper
dermis. Immunohistochemistry revealed positive staining of these cells for CD3 and CD8
(<xref ref-type="fig" rid="f02">Figure 2</xref>) without staining for CD4, CD30 and
CD56, consistent with the diagnosis of pagetoid reticulosis (PR) - Woringer-Kolopp
disease (WKD). The microbiological examinations of the skin were negative. Three weeks
later the patient developed several nummular erythematous lesions with a scaling border
scattered on the legs (<xref ref-type="fig" rid="f03">Figure 3</xref>). We repeated the
biopsy, which revealed identical findings plus positive staining for CD45 and a
proliferative index of 90% (Ki67). Subsequently, these lesions increased in size,
assuming the shape of the original plaque and a diagnosis of Ketron-Goodman disease
(KGD) was established. The patient started treatment once daily with betamethasone
dipropionate ointment and, simultaneously, was referred to the haematological outpatient
department to exclude systemic involvement. All tests were normal, including the
peripheral blood immunophenotyping, the bone marrow biopsy and the
thoracoabdomino-pelvic computed tomography scans. After 4 months of therapy with topical
betamethasone dipropionate, all the lesions cleared, with the exception of a single
lesion on the left foot, which was submitted to radiotherapy and resolved in 4 months.
In a follow-up over 2 years the patient has remained free of signs and symptoms.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Erythematous brownish plaque surrounded by a raised erythematous red border with
some erosions</p>
        </caption>
        <graphic xlink:href="abd-88-05-0824-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>A pathological infiltration of the epidermis by large-sized cells, single or
arranged in clusters and dermal fibrosis containing these cells on H&amp;E 10x
(a). Atypical large cells displaying vacuolated, abundant cytoplasm and big,
hyperchromatic, pleomorphic nuclei on H&amp;E 40x (b). Immunohistochemistry with
positive staining for CD8 (c) and CD3 (d)</p>
        </caption>
        <graphic xlink:href="abd-88-05-0824-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Nummular erythematous lesions scattered on the legs (a) in close detail displaying
a scaling border (b)</p>
        </caption>
        <graphic xlink:href="abd-88-05-0824-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Pagetoid reticulosis is a low-grade rare malignant variant of mycosis fungoides (MF)
characterized by the presence of localized patches or plaques, but usually presents as a
solitary lesion that is commonly localized on the extremities, with an intraepidermal
proliferation of neoplastic T cells that may have either a
CD4<sup>+</sup>,CD8<sup>-</sup>or a
CD4<sup>-</sup>,CD8<sup>+</sup>phenotype.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> KGD was initially described as a disseminated type of
PR.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> However, according to the
most recent classification consensus for cutaneous lymphomas, KGD would currently be
more likely to be classified as aggressive epidermotropic CD8 T-cutaneous lymphoma,
cutaneous gamma/delta T-lymphoma, or tumor-stage MF, depending on the
clinical-histological picture.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> The
term PR should only be used for the localized type - WKD.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Our case raises some issues in the light of recent
classification consensus.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Our patient
was initially diagnosed with localized PR - WKD, but then developed widespread lesions
on the legs which, together with the histopathology and immunophenotype
(CD45<sup>+</sup>, CD56<sup>-</sup>) displaying an high proliferative index, led to a
reclassification for KGD.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> According
to the classification consensus, this would be in line with a diagnosis of aggressive
CD8 T-cutaneous lymphoma.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
Nevertheless there were no signs of aggressive clinical behavior or necrotic
keratinocytes in histopathology, which provided us with the motive to continue with a
low-grade treatment regimen. The preferred mode of treatment for PR is radiotherapy and,
in some cases, topical treatment with nitrogen mustard or steroids.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Surgical excision was used in the past
for few small lesions, but the excellent response to topical and/or radiation therapy
rendered surgical intervention obsolete.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup> Localized PR has good
prognosis without extracutaneous dissemination or disease-related deaths.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> In contrast, the few published cases of
KGD report fatal outcomes, systemic involvement and interferon therapy, with an 8-month
followup without relapse.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup> In our case, a follow-up of 2 years
without recurrences or systemic involvement favors an indolent form of cutaneous
T-lymphoma. Long-term observation is however necessary, considering that even if the
cutaneous lesions clear up this may not mean resolution of the disease, since the
disease may recur as long as 10 years after therapy.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn id="fn03" fn-type="other">
        <p>* Work performed at the Department of Dermatology and Venereology, Centro Hospitalar
S&#xE3;o Jo&#xE3;o, EPE - Porto, Portugal</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willemze</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Burg</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cerroni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Berti</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>WHO-EORTC classification for cutaneous lymphomas</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>105</volume>
          <fpage>3768</fpage>
          <lpage>3785</lpage>
          <pub-id pub-id-type="pmid">15692063</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steffen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Ketron-Goodman disease, Woringer-Kolopp disease, and pagetoid
reticulosis</article-title>
          <source>Am J Dermatopathol</source>
          <year>2005</year>
          <volume>27</volume>
          <fpage>68</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">15677982</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sterry</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Hauschild</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Loss of leucocyte common antigen (CD45) on atypical lymphocytes in the
localized but not disseminated type of Pagetoid reticulosis</article-title>
          <source>Br J Dermatol</source>
          <year>1999</year>
          <volume>125</volume>
          <fpage>238</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="pmid">1832931</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marta</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Gouv&#xEA;a</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Haddad</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Mycosis fungoides: case report treated with
radiotherapy</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>561</fpage>
          <lpage>564</lpage>
          <pub-id pub-id-type="pmid">21738977</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sueki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Iijima</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Disseminated pagetoid reticulosis (Ketron-Goodman disease): six-year
follow-up</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2002</year>
          <volume>47</volume>
          <fpage>S183</fpage>
          <lpage>S186</lpage>
          <pub-id pub-id-type="pmid">12140457</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlesimo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tammaro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mari</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fidanza</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Narcisi</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A Case of Ketron-Goodman Disease</article-title>
          <source>Case Rep Dermatol</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>39</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">20652112</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
